lorazepam has been researched along with Acute Respiratory Distress Syndrome in 5 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Naloxone 2 mg by gastric tube every 8 hours for 8 days was started; the dosage then was increased to 4 mg every 8 hours." | 1.32 | Enteral administration of naloxone for treatment of opioid-associated intragastric feeding intolerance. ( Bloom, K; Liebl, MG; Mixides, G, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shudofsky, KN | 1 |
| Janssen, PKC | 1 |
| Foudraine, N | 1 |
| le Noble, JLML | 1 |
| Lavezzi, WA | 1 |
| Capacchione, JF | 1 |
| Muldoon, SM | 1 |
| Sambuughin, N | 1 |
| Bina, S | 1 |
| Steele, D | 1 |
| Brandom, BW | 1 |
| Multz, AS | 1 |
| Mixides, G | 1 |
| Liebl, MG | 1 |
| Bloom, K | 1 |
| McDonald, CF | 1 |
| Thomson, SA | 1 |
| Scott, NC | 1 |
| Scott, W | 1 |
| Grant, IW | 1 |
| Crompton, GK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Randomized Trial of Enteral Naloxone Versus a Traditional Bowel Regimen in Prevention of Constipation and Decreased Gastric Motility in Critically Ill Trauma Patients[NCT00799201] | Phase 4 | 3 participants (Actual) | Interventional | 2007-08-31 | Terminated (stopped due to Naloxone became unavailable due to manufacturing shortatges requiring the study to be terminated.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for lorazepam and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome.
Topics: Aged; Continuous Renal Replacement Therapy; COVID-19; COVID-19 Drug Treatment; Critical Illness; Dee | 2022 |
Case report: Death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old.
Topics: Child; Diazepam; Emergency Medical Services; Emergency Service, Hospital; Fatal Outcome; Humans; Hyp | 2013 |
Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal.
Topics: Acinetobacter Infections; Adult; Analgesics, Opioid; Dexmedetomidine; Fentanyl; Humans; Hypnotics an | 2003 |
Enteral administration of naloxone for treatment of opioid-associated intragastric feeding intolerance.
Topics: Adult; Catheters, Indwelling; Cross Infection; Drug Administration Schedule; Enteral Nutrition; Fata | 2004 |
Benzodiazepine-opiate antagonism--a problem in intensive-care therapy.
Topics: Adolescent; Animals; Anti-Anxiety Agents; Critical Care; Drug Interactions; Heroin; Humans; Lorazepa | 1986 |